BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 12958109)

  • 1. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea.
    Abernethy AP; Currow DC; Frith P; Fazekas BS; McHugh A; Bui C
    BMJ; 2003 Sep; 327(7414):523-8. PubMed ID: 12958109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, multi-site, crossover, placebo-controlled equivalence study of morning versus evening once-daily sustained-release morphine sulfate in people with pain from advanced cancer.
    Currow DC; Plummer JL; Cooney NJ; Gorman D; Glare PA
    J Pain Symptom Manage; 2007 Jul; 34(1):17-23. PubMed ID: 17601560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of low-dose morphine on perceived sleep quality in patients with refractory breathlessness: A hypothesis generating study.
    Martins RT; Currow DC; Abernethy AP; Johnson MJ; Toson B; Eckert DJ
    Respirology; 2016 Feb; 21(2):386-91. PubMed ID: 26560987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study.
    Currow DC; McDonald C; Oaten S; Kenny B; Allcroft P; Frith P; Briffa M; Johnson MJ; Abernethy AP
    J Pain Symptom Manage; 2011 Sep; 42(3):388-99. PubMed ID: 21458217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended-Release Morphine for Chronic Breathlessness in Pulmonary Arterial Hypertension-A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
    Ferreira DH; Ekström M; Sajkov D; Vandersman Z; Eckert DJ; Currow DC
    J Pain Symptom Manage; 2018 Oct; 56(4):483-492. PubMed ID: 30031217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term opioids for breathlessness in stable chronic heart failure: a randomized controlled trial.
    Oxberry SG; Torgerson DJ; Bland JM; Clark AL; Cleland JG; Johnson MJ
    Eur J Heart Fail; 2011 Sep; 13(9):1006-12. PubMed ID: 21712288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regular, sustained-release morphine for chronic breathlessness: a multicentre, double-blind, randomised, placebo-controlled trial.
    Currow D; Louw S; McCloud P; Fazekas B; Plummer J; McDonald CF; Agar M; Clark K; McCaffrey N; Ekström MP;
    Thorax; 2020 Jan; 75(1):50-56. PubMed ID: 31558624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of sustained-release morphine on breathlessness and quality of life in severe chronic obstructive pulmonary disease.
    Poole PJ; Veale AG; Black PN
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1877-80. PubMed ID: 9620921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic breathlessness: Breathlessness, Exertion And Morphine Sulfate (BEAMS) study protocol.
    Currow D; Watts GJ; Johnson M; McDonald CF; Miners JO; Somogyi AA; Denehy L; McCaffrey N; Eckert DJ; McCloud P; Louw S; Lam L; Greene A; Fazekas B; Clark KC; Fong K; Agar MR; Joshi R; Kilbreath S; Ferreira D; Ekström M;
    BMJ Open; 2017 Jul; 7(7):e018100. PubMed ID: 28716797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, randomized, crossover comparison between single-dose and double-dose immediate-release oral morphine at bedtime in cancer patients.
    Dale O; Piribauer M; Kaasa S; Moksnes K; Knobel H; Klepstad P
    J Pain Symptom Manage; 2009 Jan; 37(1):68-76. PubMed ID: 18504090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant pain.
    Nicholson B; Ross E; Sasaki J; Weil A
    Curr Med Res Opin; 2006 Aug; 22(8):1503-14. PubMed ID: 16870075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Sustained-Release Morphine for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease on Health Status: A Randomized Clinical Trial.
    Verberkt CA; van den Beuken-van Everdingen MHJ; Schols JMGA; Hameleers N; Wouters EFM; Janssen DJA
    JAMA Intern Med; 2020 Oct; 180(10):1306-1314. PubMed ID: 32804188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two doses of oral sustained-release tramadol do not reduce pain or morphine consumption after modified radical mastectomy: a randomized, double blind, placebo-controlled trial.
    Thienthong S; Krisanaprakornkit W; Taesiri W; Thaninsurat N; Utsahapanich S; Klaichanad C
    J Med Assoc Thai; 2004 Jan; 87(1):24-32. PubMed ID: 14971531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blinded Patient Preference for Morphine Compared to Placebo in the Setting of Chronic Refractory Breathlessness--An Exploratory Study.
    Ferreira DH; Silva JP; Quinn S; Abernethy AP; Johnson MJ; Oxberry SG; Currow DC
    J Pain Symptom Manage; 2016 Feb; 51(2):247-54. PubMed ID: 26598037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative intravenous morphine consumption, pain scores, and side effects with perioperative oral controlled-release oxycodone after lumbar discectomy.
    Blumenthal S; Min K; Marquardt M; Borgeat A
    Anesth Analg; 2007 Jul; 105(1):233-7. PubMed ID: 17578980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, placebo-controlled, cross-over pilot study to assess the effects of long-term opioid drug consumption and subsequent abstinence in chronic noncancer pain patients receiving controlled-release morphine.
    Cowan DT; Wilson-Barnett J; Griffiths P; Vaughan DJ; Gondhia A; Allan LG
    Pain Med; 2005; 6(2):113-21. PubMed ID: 15773875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy and safety of once-daily dosing of a novel, prolonged-release oral morphine tablet compared with twice-daily dosing of a standard controlled-release morphine tablet in patients with cancer pain: a randomized, double-blind, exploratory crossover study.
    Ridgway D; Sopata M; Burneckis A; Jespersen L; Andersen C
    J Pain Symptom Manage; 2010 Apr; 39(4):712-20. PubMed ID: 20413058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of benzodiazepines in breathlessness: a single site, open label pilot of sustained release morphine together with clonazepam.
    Allcroft P; Margitanovic V; Greene A; Agar MR; Clark K; Abernethy AP; Currow DC
    J Palliat Med; 2013 Jul; 16(7):741-4. PubMed ID: 23597092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain.
    van Seventer R; Smit JM; Schipper RM; Wicks MA; Zuurmond WW
    Curr Med Res Opin; 2003; 19(6):457-69. PubMed ID: 14594516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Morphine tablets for chronic non-tumor-induced pain. Which factors modify the success or failure of a long-term therapy?].
    Schulzeck S; Gleim M; Maier C
    Anaesthesist; 1993 Aug; 42(8):545-56. PubMed ID: 8368476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.